Current Evidence of Probiotics in Pediatrics with Short Bowel Syndrome, Is It Safe and Beneficial? A Literature Review
DOI:
https://doi.org/10.58427/apghn.4.1.2025.23-30Keywords:
children, intestinal failure, probiotics , short bowel syndromeAbstract
Background: Short Bowel Syndrome (SBS) presents significant challenges in pediatric care, particularly due to its high incidence in neonates and the associated health burdens, including elevated mortality rates primarily from hepatic failure and sepsis. SBS in infants and young children primarily arises from congenital defects or acquired conditions that necessitate significant bowel resection. The predominant cause of SBS during the neonatal period is necrotizing enterocolitis (NEC), accounting for 35% to 50% of cases. In older children, SBS is frequently associated with midgut volvulus or traumatic injuries.
Discussion: Managing pediatric SBS requires a multidisciplinary approach that involves evaluating dietary, pharmacology, and surgical factors. Key strategies focus on improving absorptive capacity, promoting intestinal adaptation, and regulating bowel motility. In infants and young children, SBS often leads to a range of complications, including nutrient deficiencies, fluid imbalances, and growth delays. The condition necessitates careful medical management to address these challenges and promote optimal health outcomes. Recent studies have investigated probiotics as an adjuvant treatment for SBS, demonstrating enhanced growth, nutritional status, and inhibition of harmful microbes in afflicted children
Conclusion: The use of probiotics in children with SBS has shown both safety and beneficial effects, making it a feasible alternative therapy in routine medical practice. However, the lack of significant clinical data highlights the need for more study to better understand the efficacy of probiotics in the treatment of SBS.
References
Goulet O, Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology. 2006;130(2 Suppl 1):S16-28. https://doi.org/10.1053/j.gastro.2005.12.002 DOI: https://doi.org/10.1053/j.gastro.2005.12.002
Goulet O, Olieman J, Ksiazyk J, Spolidoro J, Tibboe D, Köhler H, et al. Neonatal short bowel syndrome as a model of intestinal failure: physiological background for enteral feeding. Clin Nutr. 2013;32(2):162-71. https://doi.org/10.1016/j.clnu.2012.09.007 DOI: https://doi.org/10.1016/j.clnu.2012.09.007
Amin SC, Pappas C, Iyengar H, Maheshwari A. Short bowel syndrome in the NICU. Clin Perinatol. 2013;40(1):53-68. https://doi.org/10.1016/j.clp.2012.12.003 DOI: https://doi.org/10.1016/j.clp.2012.12.003
Wales PW, Christison-Lagay ER. Short bowel syndrome: epidemiology and etiology. Semin Pediatr Surg. 2010;19(1):3-9. https://doi.org/10.1053/j.sempedsurg.2009.11.001 DOI: https://doi.org/10.1053/j.sempedsurg.2009.11.001
Bruzoni M, Sudan DL, Cusick RA, Thompson JS. Comparison of short bowel syndrome acquired early in life and during adolescence. Transplantation. 2008;86(1):63-6. https://doi.org/10.1097/TP.0b013e3181734995 DOI: https://doi.org/10.1097/TP.0b013e3181734995
Spencer AU, Kovacevich D, McKinney-Barnett M, Hair D, Canham J, Maksym C, Teitelbaum DH. Pediatric short-bowel syndrome: the cost of comprehensive care. Am J Clin Nutr. 2008;88(6):1552-9. https://doi.org/10.3945/ajcn.2008.26007 DOI: https://doi.org/10.3945/ajcn.2008.26007
Spencer AU, Neaga A, West B, Safran J, Brown P, Btaiche I, et al. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg. 2005;242(3):403-9; discussion 9-12. https://doi.org/10.1097/01.sla.0000179647.24046.03 DOI: https://doi.org/10.1097/01.sla.0000179647.24046.03
Martínez M, Fabeiro M, Dalieri M, Barcellandi P, Prozzi M, Hernández J, et al. Outcome and survival of pediatric short bowel syndrome (sbs). Nutrición hospitalaria : organo oficial de la Sociedad Española de Nutrición Parenteral y Enteral. 2011;26:239-42
Uchida K, Takahashi T, Inoue M, Morotomi M, Otake K, Nakazawa M, et al. Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome. Pediatr Surg Int. 2007;23(3):243-8. https://doi.org/10.1007/s00383-006-1866-6 DOI: https://doi.org/10.1007/s00383-006-1866-6
Kanamori Y, Sugiyama M, Hashizume K, Yuki N, Morotomi M, Tanaka R. Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J Pediatr Surg. 2004;39(11):1686-92. https://doi.org/10.1016/j.jpedsurg.2004.07.013 DOI: https://doi.org/10.1016/j.jpedsurg.2004.07.013
Caporilli C, Giannì G, Grassi F, Esposito S. An overview of short-bowel syndrome in pediatric patients: focus on clinical management and prevention of complications. Nutrients. 2023;15(10). https://doi.org/10.3390/nu15102341 DOI: https://doi.org/10.3390/nu15102341
McLaughlin CM, Channabasappa N, Pace J, Nguyen H, Piper HG. Growth trajectory in children with short bowel syndrome during the first 2 years of life. J Pediatr Gastroenterol Nutr. 2018;66(3):484-8. https://doi.org/10.1097/mpg.0000000000001762 DOI: https://doi.org/10.1097/MPG.0000000000001762
Massironi S, Cavalcoli F, Rausa E, Invernizzi P, Braga M, Vecchi M. Understanding short bowel syndrome: current status and future perspectives. Dig Liver Dis. 2020;52(3):253-61. https://doi.org/10.1016/j.dld.2019.11.013 DOI: https://doi.org/10.1016/j.dld.2019.11.013
Shakhsheer BA, Warner BW. Short bowel syndrome. Curr Treat Options Pediatr. 2019;5(4):494-505.https://doi.org/10.1007/s40746-019-00179-y DOI: https://doi.org/10.1007/s40746-019-00179-y
Casaccia G, Trucchi A, Spirydakis I, Giorlandino C, Aite L, Capolupo I, et al. Congenital intestinal anomalies, neonatal short bowel syndrome, and prenatal/neonatal counseling. J Pediatr Surg. 2006;41(4):804-7. https://doi.org/10.1016/j.jpedsurg.2005.12.022 DOI: https://doi.org/10.1016/j.jpedsurg.2005.12.022
Piper HG. Intestinal microbiota in short bowel syndrome. Semin Pediatr Surg. 2018;27(4):223-8. https://doi.org/10.1053/j.sempedsurg.2018.07.007 DOI: https://doi.org/10.1053/j.sempedsurg.2018.07.007
Engelstad HJ, Barron L, Moen J, Wylie TN, Wylie K, Rubin DC, et al. Remnant small bowel length in pediatric short bowel syndrome and the correlation with intestinal dysbiosis and linear growth. J Am Coll Surg. 2018;227(4):439-49. https://doi.org/10.1016/j.jamcollsurg.2018.07.657 DOI: https://doi.org/10.1016/j.jamcollsurg.2018.07.657
Cole CR, Ziegler TR. Small bowel bacterial overgrowth: a negative factor in gut adaptation in pediatric SBS. Curr Gastroenterol Rep. 2007;9(6):456-62. https://doi.org/10.1007/s11894-007-0059-3 DOI: https://doi.org/10.1007/s11894-007-0059-3
McDuffie LA, Bucher BT, Erwin CR, Wakeman D, White FV, Warner BW. Intestinal adaptation after small bowel resection in human infants. J Pediatr Surg. 2011;46(6):1045-51. https://doi.org/10.1016/j.jpedsurg.2011.03.027 DOI: https://doi.org/10.1016/j.jpedsurg.2011.03.027
Muto M, Kaji T, Onishi S, Yano K, Yamada W, Ieiri S. An overview of the current management of short-bowel syndrome in pediatric patients. Surg Today. 2022;52(1):12-21. https://doi.org/10.1007/s00595-020-02207-z DOI: https://doi.org/10.1007/s00595-020-02207-z
Merras-Salmio L, Pakarinen MP. Infection prevention and management in pediatric short bowel syndrome. Front Pediatr. 2022;10:864397. https://doi.org/10.3389/fped.2022.864397 DOI: https://doi.org/10.3389/fped.2022.864397
Chandra R, Kesavan A. Current treatment paradigms in pediatric short bowel syndrome. Clin J Gastroenterol. 2018;11(2):103-12. https://doi.org/10.1007/s12328-017-0811-7 DOI: https://doi.org/10.1007/s12328-017-0811-7
World Health Organization. Guidelines for the evaluation of probiotics in food. Canada2002. Available from: https://isappscience.org/wp-content/uploads/2019/04/probiotic_guidelines.pdf.
Piper H, Coughlin L, Hussain S, Nguyen V, Channabasappa N, Koh A. The impact of lactobacillus probiotics on the gut microbiota in children with short bowel syndrome. Journal of Surgical Research. 2020;251:112-8. https://doi.org/10.1016/j.jss.2020.01.024 DOI: https://doi.org/10.1016/j.jss.2020.01.024
Ewaschuk J, Endersby R, Thiel D, Diaz H, Backer J, Ma M, et al. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology. 2007;46(3):841-50. https://doi.org/10.1002/hep.21750 DOI: https://doi.org/10.1002/hep.21750
Barc MC, Charrin-Sarnel C, Rochet V, Bourlioux F, Sandré C, Boureau H, et al. Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: Influence of Saccharomyces boulardii. Anaerobe. 2008;14(4):229-33. https://doi.org/10.1016/j.anaerobe.2008.04.003 DOI: https://doi.org/10.1016/j.anaerobe.2008.04.003
Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Adv Nutr. 2019;10(suppl_1):S49-s66. https://doi.org/10.1093/advances/nmy063 DOI: https://doi.org/10.1093/advances/nmy063
Shehata AA, Yalçın S, Latorre JD, Basiouni S, Attia YA, Abd El-Wahab A, et al. Probiotics, prebiotics, and phytogenic substances for optimizing gut health in poultry. Microorganisms. 2022;10(2). https://doi.org/10.3390/microorganisms10020395 DOI: https://doi.org/10.3390/microorganisms10020395
Markowiak-Kopeć P, Śliżewska K. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients. 2020;12(4). https://doi.org/10.3390/nu12041107 DOI: https://doi.org/10.3390/nu12041107
Bartholome AL, Albin DM, Baker DH, Holst JJ, Tappenden KA. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr. 2004;28(4):210-22; discussion 22-3. https://doi.org/10.1177/0148607104028004210 DOI: https://doi.org/10.1177/0148607104028004210
Fayol-Messaoudi D, Berger CN, Coconnier-Polter MH, Liévin-Le Moal V, Servin AL. pH-, lactic acid-, and non-lactic acid-dependent activities of probiotic lactobacilli against salmonella enterica serovar typhimurium. Appl Environ Microbiol. 2005;71(10):6008-13. https://doi.org/10.1128/aem.71.10.6008-6013.2005 DOI: https://doi.org/10.1128/AEM.71.10.6008-6013.2005
Sherman PM, Johnson-Henry KC, Yeung HP, Ngo PS, Goulet J, Tompkins TA. Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun. 2005;73(8):5183-8. https://doi.org/10.1128/iai.73.8.5183-5188.2005 DOI: https://doi.org/10.1128/IAI.73.8.5183-5188.2005
Matzaras R, Nikopoulou A, Protonotariou E, Christaki E. Gut microbiota modulation and prevention of dysbiosis as an alternative approach to antimicrobial resistance: a narrative review. Yale J Biol Med. 2022;95(4):479-94
Vanderhoof JA, Young RJ, Murray N, Kaufman SS. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr. 1998;27(2):155-60. https://doi.org/10.1097/00005176-199808000-00005 DOI: https://doi.org/10.1002/j.1536-4801.1998.tb01126.x
Candy DC, Densham L, Lamont LS, Greig M, Lewis J, Bennett H, Griffiths M. Effect of administration of Lactobacillus casei shirota on sodium balance in an infant with short bowel syndrome. J Pediatr Gastroenterol Nutr. 2001;32(4):506-8. https://doi.org/10.1097/00005176-200104000-00027 DOI: https://doi.org/10.1002/j.1536-4801.2001.tb07311.x
Kanamori Y, Hashizume K, Sugiyama M, Morotomi M, Yuki N. Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure. Dig Dis Sci. 2001;46(9):2010-6. https://doi.org/10.1023/a:1010611920750 DOI: https://doi.org/10.1023/A:1010611920750
Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr. 2004;38(4):457-8. https://doi.org/10.1097/00005176-200404000-00017 DOI: https://doi.org/10.1002/j.1536-4801.2004.tb12198.x
De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J. 2005;24(3):278-80. https://doi.org/10.1097/01.inf.0000154588.79356.e6 DOI: https://doi.org/10.1097/01.inf.0000154588.79356.e6
Ku WH, Lau DCY, Huen KF. Probiotics provoked d-lactic acidosis in short bowel syndrome: case report and literature review. Hong Kong Journal of Paediatrics. 2006;11
Munakata S, Arakawa C, Kohira R, Fujita Y, Fuchigami T, Mugishima H. A case of D-lactic acid encephalopathy associated with use of probiotics. Brain Dev. 2010;32(8):691-4. https://doi.org/10.1016/j.braindev.2009.09.024 DOI: https://doi.org/10.1016/j.braindev.2009.09.024
Published
Issue
Section
License
Copyright (c) 2025 Vianca Samara Andhary, Rafi Alfian Razan, I Gusti Ayu Nyoman Partiwi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
